Entero Therapeutics
Why Robinhood?
You can watch ENTO and buy or sell other stocks, ETFs, and their options commission-free!About ENTO
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
ENTO Key Statistics
Stock Snapshot
Entero Therapeutics(ENTO) stock is priced at $4.78, giving the company a market capitalization of 20.19M. It carries a P/E multiple of -1.21.
During the trading day, Entero Therapeutics(ENTO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 126.48K.
Over the past 52 weeks, Entero Therapeutics(ENTO) stock has traded between a high of $5.84 and a low of $1.06.
Over the past 52 weeks, Entero Therapeutics(ENTO) stock has traded between a high of $5.84 and a low of $1.06.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.